PTC
PBYI icon

Private Trust Company’s Puma Biotechnology PBYI Stock Holding History

Private Trust Company’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14
Closed -$3K – 923
2014
Q3 		$3K Buy
14
+2
+17% +$411 ﹤0.01% 1489
2014
Q2 		$1K Hold
12
– – ﹤0.01% 1791
2014
Q1 		$1K Buy
12
+2
+20% +$235 ﹤0.01% 1663
2013
Q4 		$1K Buy
+10
New +$587 ﹤0.01% 1659

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Private Trust Company's PBYI Position: Q4 2014 in Review

Private Trust Company sold out of Puma Biotechnology (PBYI) in Q4 2014, closing a stake of 14 shares — an estimated $3K sold.

Private Trust Company first reported a position in PBYI in Q4 2013 and held it in 4 quarters. The position peaked at $3K in Q3 2014. 189 funds tracked by Wall St. Rank hold PBYI as of Q4 2014.

  • Private Trust Company reported no remaining Puma Biotechnology position as of Q4 2014 after selling out during the quarter.
  • Private Trust Company sold 14 Puma Biotechnology shares in Q4 2014, an estimated $3K.
  • Private Trust Company first reported a position in Puma Biotechnology in Q4 2013 and held it in 4 quarters.
  • Private Trust Company's Puma Biotechnology position peaked at $3K in Q3 2014.
  • 189 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.